10209860

Nawroth F

1999

[Persistent anovulation following laparoscopic electrocoagulation of the ovarian surface in a patient with polycystic ovary syndrome (PCOS)].

10212834

Nestler JE

1998

Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions.

10216519

Kurioka H

1999

Diagnostic difficulty in polycystic ovary syndrome due to an LH-beta-subunit variant.

10219066

Nestler JE

1999

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.

10221214

Kaaijk EM

1999

Clinical outcome after unilateral oophorectomy in patients with polycystic ovary syndrome.

10221215

Cagnacci A

1999

Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism.

10221612

Vinker S

1999

Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?

10221615

El-Sheikh MM

1999

Limited ovarian stimulation results in the recovery of mature oocytes in polycystic ovarian disease patients: a preliminary report.

10221682

Doldi N

1999

Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome.

10221684

Fulghesu AM

1999

Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome.

10221685

Buckett WM

1999

Ovarian stromal echogenicity in women with normal and polycystic ovaries.

10224741

Gj?nnaess H

1998

Treatment in polycystic ovarian syndrome (PCOS) with emphasis on ovarian electrocautery.

10224797

Andrzejewski L

1998

[Surgically induced ovulation in the treatment of sterility due to polycystic ovary syndrome and the course of present pregnancies and deliveries].

10226125

Taskin O

1999

Adhesion formation after microlaparoscopic and laparoscopic ovarian coagulation for polycystic ovary disease.

10227562

Day C

1999

Thiazolidinediones: a new class of antidiabetic drugs.

10229031

Andolf E

1999

Pelvic ultrasonography cannot alone be used to diagnose pubertal anomalies.

10231064

Al-Took S

1999

Ovarian stromal echogenicity in women with clomiphene citrate-sensitive and clomiphene citrate-resistant polycystic ovary syndrome.

10323370

Sarlis NJ

1999

Administration of metformin to a diabetic woman with extreme hyperandrogenemia of nontumoral origin: management of infertility and prevention of inadvertent masculinization of a female fetus.

10323405

Tapanainen JS

1999

A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

10333369

Messinis IE

1999

Leptin in human reproduction.

10333916

Ehrmann DA

1999

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

10334972

Ellis JA

1999

Insulin gene polymorphism and premature male pattern baldness in the general population.

10335468

Bider D

1999

Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease.

10336020

Jacobs HS

1999

Leptin, polycystic ovaries and polycystic ovary syndrome.

10342846

Mann RJ

1999

Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure.

10349136

Garc?a Rudaz MC

1999

[Polycystic ovarian syndrome. GnRH pulse generator defect?].

10352918

Solomon CG

1999

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.

10352919

Rosenfield RL

1999

Ovarian and adrenal function in polycystic ovary syndrome.

10352920

Marshall JC

1999

Neuroendocrine aspects of polycystic ovary syndrome.

10352921

Giudice LC

1999

Growth factor action on ovarian function in polycystic ovary syndrome.

10352922

Dunaif A

1999

Insulin action in the polycystic ovary syndrome.

10352923

Franks S

1999

Insulin action in the normal and polycystic ovary.

10352924

Legro RS

1999

Polycystic ovary syndrome. Phenotype to genotype.

10352925

Chang RJ

1999

Diagnosis of polycystic ovary syndrome.

10352926

Rittmaster RS

1999

Antiandrogen treatment of polycystic ovary syndrome.

10352927

Ehrmann DA

1999

Insulin-lowering therapeutic modalities for polycystic ovary syndrome.

10352928

Amowitz LL

1999

Cardiovascular consequences of polycystic ovary syndrome.

10357954

Sir-Petermann T

1999

Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?

10357955

Fridstr?m M

1999

Effect of prednisolone on serum and follicular fluid androgen concentrations in women with polycystic ovary syndrome undergoing in-vitro fertilization.

10357963

Hjollund NH

1999

Is glycosylated haemoglobin a marker of fertility? A follow-up study of first-pregnancy planners.

10358853

Futterweit W

1999

Polycystic ovary syndrome: clinical perspectives and management.

10360913

Kele?timur F

1999

Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome.

10368795

Martinez-Guisasola J

1999

Circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome.

10370713

Kahn JA

1999

Polycystic ovary syndrome.

10372683

Carmina E

1999

Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.

10372729

Wahrenberg H

1999

Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.

10374115

Engmann L

1999

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology.

10374136

Homburg R

1999

Growth hormone kinetics in polycystic ovary syndrome.

10376368

Davis S

1999

Syndromes of hyperandrogenism in women.

10376864

Gj?nnaess H

1999

Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.

10379878

Strauss JF 3rd

1999

Molecular mysteries of polycystic ovary syndrome.

10379885

Kumar TR

1999

Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.

10379893

Nelson VL

1999

Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.

10380300

Borgfeldt C

1999

Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old.

10384805

Gordon CM

1999

Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome.

10389470

Beckers A

1999

[Hyperandrogenism: clinical aspects, investigation and treatment].

10391538

Barisic D

1999

Pregnancy following the laparoscopic bipolar electrocoagulation of polycystic ovaries resistant to medicamentous ovulation induction--a case report.

10392989

F?nichel P

1999

Polycystic ovary syndrome in autoimmune disease.

10399058

Battaglia C

1999

Doppler, ultrasonographic and endocrinological environment with regard to the number of small subcapsular follicles in polycystic ovary syndrome.

10402368

van Hooff MH

1999

Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome.

10402371

Pe?arrubia J

1999

Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin.

10402420

Sohan K

1999

Local reaction to s.c. injections of a recombinant gonadotrophin preparation possibly related to the osmolality of the reconstituted solution.

10404813

Jakimiuk AJ

1999

5alpha-reductase activity in women with polycystic ovary syndrome.

10409902

Heim SC

1999

[Polycystic ovary syndrome--only relevant in reproductive medicine?].

10411866

Odunsi K

1999

A paradigm for finding genes for a complex human trait: polycystic ovary syndrome and follistatin.

10411917

Urbanek M

1999

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

10416303

Aquino Carlos P

1999

[The role of insulin-like growth factor in polycystic ovary syndrome].

10417739

Sobel BE

1999

The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

10418858

Sobel BE

1999

Insulin resistance and thrombosis: a cardiologist's view.

10419000

Kashar-Miller M

1999

Heritability and the risk of developing androgen excess.

10419001

Franks S

1999

Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis.

10420802

Zwimpfer J

1999

[Hirsutism. Polycystic ovaries with suspected metabolic syndrome].

10420963

Zornoza A

1997

[Surgical options in the treatment of polycystic ovary syndrome].

10422469

Chardonnens D

1999

[Polycystic ovaries: when to suspect the diagnosis?].

10426590

Sakai A

1999

Induction of ovulation by Sairei-to for polycystic ovary syndrome patients.

10428142

Kondoh Y

1999

Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.

10428143

Good C

1999

Bone mineral density and body composition in lean women with polycystic ovary syndrome.

10428144

Gal M

1999

Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome.

10428145

Aci?n P

1999

Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.

10431232

Eaves IA

1999

Transmission ratio distortion at the INS-IGF2 VNTR.

10432126

Radon PA

1999

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

10433180

Thys-Jacobs S

1999

Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.

10438110

Lass A

1999

The role of ovarian volume in reproductive medicine.

10438402

Roh JS

1999

Increased peripheral androgen activity in infertile Korean women with polycystic ovaries.

10438405

T?ras MB

1999

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome.

10438447

Kele?timur F

1999

Relationship of ovarian stromal volume and serum 17-hydroxyprogesterone concentrations in patients with PCOS.

10438996

De Leo V

1999

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.

10439012

Cohen DP

1999

Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome.

10443703

Weil S

1999

Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

10443707

Ciampelli M

1999

Comment on Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome.

10453357

Poretsky L

1999

The insulin-related ovarian regulatory system in health and disease.

10456184

Dewailly D

1999

[Physiopathology of polycystic ovary syndrome].

10456185

Franks S

1999

Genetic abnormalities in polycystic ovary syndrome.

10456187

Macklon NS

1999

Progress in ovarian stimulation.

10459452

Zournatzi V

1999

Growth hormone response to oral glucose tolerance and insulin tolerance tests in patients with PCOS.

10462962

Warenik-Szymankiewicz A

1999

[Surgical treatment of polycystic ovary syndrome].

10462969

Powolny M

1999

[A case of coexistence of polycystic ovary syndrome and ovarian carcinoma].

10462973

Katulski K

1999

[Molecular background of hyperandrogenism of ovarian origin].

10462984

Micinski P

1999

[Polycystic ovary syndrome in adolescent gynecology].

10462985

Mici?ski P

1999

[Acantosis nigricans in polycystic ovary syndrome].